Evidence map›Paper›PMID 25425244›Full record

ArticleJournal of magnetic resonance imaging : JMRI2015

Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation.

Matthew J Goette, Gregory M Lanza, Shelton D Caruthers, Samuel A Wickline

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Feasibility and optimization ofPhysics in medicine and biology · 2024
    Article
  2. Fluorine (Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  3. Functional Imaging Using Fluorine (Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Improvement ofMagma (New York, N.Y.) · 2019
    Article
  8. Article
  9. Recent Advances inEngineering (Beijing, China) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew J GoetteDepartment of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.
Gregory M LanzaDepartment of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.
Shelton D CaruthersDepartment of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.
Samuel A WicklineDepartment of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.

Funding

METHODS IN MOLECULAR IMAGING AND TARGETED THERAPEUTICSR01HL073646 · NHLBI · WASHINGTON UNIVERSITY · PI WICKLINE, SAMUEL A · 2004 to 2016
$13.7M
Translational Research Skills Development CoreU54HL112303 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2012 to 2016
$8.8M
Task Specific Project 3: Diffuse Optical TomographyU54CA136398 · NCI · WASHINGTON UNIVERSITY · PI GAO, FENG · 2008 to 2012
$6.0M
Theranostic Approach to Asthma Using Anti-Angiogenic NanomedicineR01HL113392 · NHLBI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M, WAGNER, ELIZABETH · 2012 to 2016
$3.3M
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERYR01CA154737 · NCI · WASHINGTON UNIVERSITY · PI LANZA, GREGORY M, PAN, DIPANJAN · 2011 to 2015
$2.4M
Targeted Nanoparticles of Bismuth Organo Complexes for Spectral CT Imaging of CorR42HL112518 · NHLBI · OCEAN NANOTECH, LLC · PI LANZA, GREGORY M, WANG, YONGQIANG ANDREW · 2012 to 2015
$1.4M
Prevention of Bladder Cancer with Broccoli SproutsR21CA100623 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ZHANG, YUESHENG · 2004 to 2005
$466k
QUANTIFYING KIDNEY INJURY AND INFLAMMATION WITH FLUORINE (19F) MRIR21DK095555 · NIDDK · WASHINGTON UNIVERSITY · PI WICKLINE, SAMUEL A · 2012 to 2013
$411k
NCI NIH HHS CA100623NCI NIH HHS CA154737NCI NIH HHS R01 CA154737NCI NIH HHS R21 CA100623NCI NIH HHS U54 CA136398NHLBI NIH HHS HL112518NHLBI NIH HHS HL113392NHLBI NIH HHS R01 HL073646NHLBI NIH HHS R01 HL113392NHLBI NIH HHS R42 HL112518NHLBI NIH HHS U54 HL112303NIDDK NIH HHS R21 DK095555
6 · The paper itself

Abstract

purposeTo improve (19) F flip angle calibration and compensate for B1 inhomogeneities in quantitative (19) F MRI of sparse molecular epitopes with perfluorocarbon (PFC) nanoparticle (NP) emulsion contrast agents. MATERIALS AND

methodsFlip angle sweep experiments on PFC-NP point source phantoms with three custom-designed (19) F/(1) H dual-tuned coils revealed a difference in required power settings for (19) F and (1) H nuclei, which was used to calculate a calibration ratio specific for each coil. An image-based correction technique was developed using B1 -field mapping on (1) H to correct for (19) F and (1) H images in two phantom experiments.

resultsOptimized (19) F peak power differed significantly from that of (1) H power for each coil (P < 0.05). A ratio of (19) F/(1) H power settings yielded a coil-specific and spatially independent calibration value (surface: 1.48 ± 0.06; semicylindrical: 1.71 ± 0.02, single-turn-solenoid: 1.92 ± 0.03). (1) H-image-based B1 correction equalized the signal intensity of (19) F images for two identical (19) F PFC-NP samples placed in different parts of the field, which were offset significantly by ~66% (P < 0.001), before correction.

conclusion(19) F flip angle calibration and B1 -mapping compensations to the (19) F images employing the more abundant (1) H signal as a basis for correction resulted in a significant change in the quantification of sparse (19) F MR signals from targeted PFC NP emulsions.

Indexed as

AlgorithmsArtifactsCalibrationEquipment DesignEquipment Failure AnalysisMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMolecular ImagingPhantoms, ImagingReproducibility of ResultsSensitivity and SpecificityB1 correctionflip angle calibrationmolecular imagingperfluorocarbon nanoparticlesquantitative 19F MRIRF power settings

Identifiers

PMID25425244
PMCPMC4442761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.